Abstract
The human lipidome comprises numerous complex lipids, dysregulation of which can contribute to the pathogenesis of a wide range of diseases. Despite the high heritability of parts of the lipidome, the genetic architecture of many circulating lipid species and their structure remains mostly unknown. Thus, we performed genome-wide association studies on 970 lipid species and 267 fatty acid composite measures using samples from the population-based Rhineland Study (n=6,096). We validated our findings using corresponding data from two other independent cohorts, including FinnGen (n=7,266) and EPIC-Potsdam (n=1,188). Out of 217 lead genomic loci, we found 135 to be novel, such as FDFT1. Using mendelian randomization and individual-level gene expression data, we identified five possible causal associations between candidate genes and corresponding lipid species, including FDFT1-diacylglycerol (16:0/18:0). Our findings provide new insights into the intricate genetic underpinnings of lipid metabolism, which may facilitate risk stratification and discovery of new therapeutic targets.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Rhineland Study is funded by the German Center for Neurodegenerative Diseases (DZNE). This work was further supported by the Diet–Body–Brain Competence Cluster in Nutrition Research funded by the Federal Ministry of Education and Research (grant number 01EA1410C), the Federal Ministry of Education and Research (FKZ :01KX2230) in the framework "PreBeDem – Mit Prävention und Behandlung gegen Demenz", the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy – EXC 2151 – 390873048, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – SFB 1454 – Project–ID 432325352, and the Helmholtz Association under the 2023 Innovation Pool. The work in EPIC-Potsdam was supported by a grant from the European Commission and the German Federal Ministry of Education and Research within the Joint Programming Initiative A Healthy Diet for a Healthy Life, within the ERA-HDHL cofounded joint call Biomarkers for Nutrition and Health (01EA1704), grants from the German Federal Ministry of Education and Research and the State of Brandenburg to the German Center for Diabetes Research (DZD) (82DZD00302, 82DZD03D03). N.A. Aziz is supported by a European Research Council Starting Grant (Number: 101041677).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Approval to undertake the Rhineland Study was obtained from the ethics committee of the University of Bonn, Medical Faculty. The study was carried out in accordance with the recommendations of the International Council for Harmonisation Good Clinical Practice standards. We obtained written informed consent from all participants in accordance with the Declaration of Helsinki. The study protocol of EPIC-Potsdam was approved by the ethics committee of the Medical Society of the State of Brandenburg, Germany, and all participants provided a statement of written informed consent before enrollment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Shared last authors.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos